Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270984
Max Phase: Preclinical
Molecular Formula: C31H44BrN11O3
Molecular Weight: 698.67
Associated Items:
ID: ALA5270984
Max Phase: Preclinical
Molecular Formula: C31H44BrN11O3
Molecular Weight: 698.67
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@@H](Cc1c[nH]c2cc(Br)ccc12)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCCc1ccccc1
Standard InChI: InChI=1S/C31H44BrN11O3/c32-21-10-11-22-20(18-41-25(22)17-21)16-26(43-27(44)23(33)8-4-13-39-30(34)35)29(46)42-24(9-5-14-40-31(36)37)28(45)38-15-12-19-6-2-1-3-7-19/h1-3,6-7,10-11,17-18,23-24,26,41H,4-5,8-9,12-16,33H2,(H,38,45)(H,42,46)(H,43,44)(H4,34,35,39)(H4,36,37,40)/t23-,24-,26+/m0/s1
Standard InChI Key: XMJWFOQCZYZBBB-KYPHJKQUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 698.67 | Molecular Weight (Monoisotopic): 697.2812 | AlogP: 0.66 | #Rotatable Bonds: 18 |
Polar Surface Area: 252.91 | Molecular Species: BASE | HBA: 6 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.12 | CX Basic pKa: 11.79 | CX LogP: -0.11 | CX LogD: -4.86 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.05 | Np Likeness Score: 0.04 |
1. Craig AJ, Ermolovich Y, Cameron A, Rodler A, Wang H, Hawkes JA, Hubert M, Björkling F, Molchanova N, Brimble MA, Moodie LWK, Svenson J.. (2023) Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents., 14 (6): [PMID:37312845] [10.1021/acsmedchemlett.3c00093] |
Source(1):